Lendway (NASDAQ:TULP – Get Free Report) issued its earnings results on Thursday. The company reported ($0.50) EPS for the quarter, Zacks reports. Lendway had a negative return on equity of 45.46% and a negative net margin of 23.23%. The company had revenue of $4.96 million for the quarter.
Lendway Price Performance
NASDAQ:TULP remained flat at $2.35 during mid-day trading on Thursday. 2,227 shares of the company were exchanged, compared to its average volume of 7,395. Lendway has a 52 week low of $2.00 and a 52 week high of $5.40. The business’s 50-day simple moving average is $2.76 and its two-hundred day simple moving average is $3.49. The stock has a market capitalization of $11.35 million, a price-to-earnings ratio of -0.53 and a beta of 2.81. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.69 and a quick ratio of 1.19.
Wall Street Analyst Weigh In
Separately, Weiss Ratings lowered Lendway from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, September 11th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has an average rating of “Sell”.
Read Our Latest Report on TULP
About Lendway
Lendway, Inc. (NASDAQ:TULP) is a real estate company focused on investing in, developing, and managing real estate assets. Through its subsidiaries, the company participates in real estate ownership and related activities, with an emphasis on identifying opportunities that may generate long-term value. Lendway’s business activities include real estate investment, property operations, development, and financing-related services. Its portfolio and projects may include residential and commercial properties, while its financing activities support real estate transactions and investments.
Read More
- Five stocks we like better than Lendway
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for Lendway Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lendway and related companies with MarketBeat.com's FREE daily email newsletter.
